A sTn double C-glycoside, sTn analogue 2, was synthesized using samarium chemistry developed in our laboratory. Complications in the oxidation reaction affording aldehyde acceptor were overcome by double protection of amide and the use of a room-temperature ionic liquid as solvent. Studies are underway to conjugate the sTn double C-glycoside hapten 2 to KLH carrier protein for biological evaluation as a vaccine.Neuraminic acids are biologically important since they occupy the terminal position of the glycans on macro-molecules outside cells and cell membranes and are involved in recognition, cell interactions, neuronal transmission, ion transport, reproduction, differentiation, epitope masking, and protection. Neuraminic acids are also involved in pathological processes including infection, inflammations, cancer, and neurological, cardiovascular, endocrinological, and autoimmune diseases. 1,2 Cell surfaces containing these terminal neuraminic acids interact with receptors, hormones, enzymes, toxins, and viruses and other pathogens that use Neu5Ac to localize on the surface of cells they infect. 3 The linkage of neuraminic acid to glycoconjugates is among the most labile glycosidic linkages and is cleaved in vitro under mildly acidic conditions. In vivo, neuraminic acidcontaining glycoconjugates are catabolized through the removal of the terminal sialic acid residue by the action of hydrolase-type enzymes called neuraminidases. A non-hydrolyzable glycosidic linkage to neuraminic acid represents is an attractive approach to design reagents for glycobiology and immunology. The replacement of the interglycosidic oxygen atom with a hydroxymethylene group using SmI 2 chemistry 4 affords a class of hydrolytically and